We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
101
MacroGenics
MGNX
$248M
$10.2M 0.12%
6,324,000
+364,000
+6% +$572K
AMD icon
102
Advanced Micro Devices
AMD
$786B
$10M 0.12%
+46,703
New +$10.5M
COR icon
103
Cencora
COR
$61.7B
$9.46M 0.11%
28,000
+20,967
+298% +$7.15M
MCK icon
104
McKesson
MCK
$103B
$9.32M 0.11%
11,363
+5,510
+94% +$4.5M
VRCA icon
105
Verrica Pharmaceuticals
VRCA
$94.7M
$9.3M 0.11%
1,118,925
+479,732
+75% +$2.66M
SRRK icon
106
Scholar Rock
SRRK
$5.74B
$8.81M 0.1%
+200,000
New +$7.5M
ZETA icon
107
Zeta Global
ZETA
$6.75B
$8.71M 0.1%
428,229
+116,140
+37% +$2.17M
INGN icon
108
Inogen
INGN
$178M
$8.49M 0.1%
1,264,000
+400,000
+46% +$3M
ORLY icon
109
O'Reilly Automotive
ORLY
$76.3B
$8.31M 0.1%
91,111
+20,715
+29% +$2.02M
ZURA icon
110
Zura Bio
ZURA
$536M
$8.17M 0.1%
1,560,000
– –
TOST icon
111
Toast
TOST
$20.2B
$8.09M 0.1%
227,753
-58,283
-20% -$2.1M
PEGA icon
112
Pegasystems
PEGA
$5.23B
$7.88M 0.09%
131,994
+45,168
+52% +$2.65M
FLUT icon
113
Flutter Entertainment
FLUT
$16.1B
$7.84M 0.09%
36,466
+35,458
+3,518% +$7.97M
TERN
114
DELISTED
Terns Pharmaceuticals
TERN
$6.97M 0.08%
+172,479
New +$3.99M
AS icon
115
Amer Sports
AS
$21.4B
$6.92M 0.08%
185,207
+18,605
+11% +$638K
DKS icon
116
Dick's Sporting Goods
DKS
$17.9B
$6.83M 0.08%
+34,488
New +$7.52M
PONY
117
Pony AI Inc
PONY
$3.39B
$6.79M 0.08%
468,000
+218,700
+88% +$3.64M
EOLS icon
118
Evolus
EOLS
$407M
$6.49M 0.08%
+976,000
New +$6.61M
BBY icon
119
Best Buy
BBY
$17.8B
$6.46M 0.08%
96,487
+1,421
+1% +$108K
SYRE icon
120
Spyre Therapeutics
SYRE
$9.06B
$6.43M 0.08%
196,426
+40,426
+26% +$1.06M
KYMR icon
121
Kymera Therapeutics
KYMR
$8.68B
$6.32M 0.08%
+81,165
New +$5.48M
OS
122
DELISTED
OneStream Inc
OS
$6.18M 0.07%
336,000
+86,000
+34% +$1.64M
SCLX icon
123
Scilex Holding
SCLX
$45.9M
$5.82M 0.07%
476,674
+410,674
+622% +$6.94M
CTOR
124
Citius Oncology
CTOR
$73M
$5.58M 0.07%
5,584,080
-2,091,831
-27% -$3M
TER icon
125
Teradyne
TER
$60.9B
$5.48M 0.07%
28,302
-8,261
-23% -$1.42M
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.